Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-14512-3, published online 30 June 2022
The original version of this Article contained an error, where a p-value was incorrect in the Results section under the subheading ‘Psychomotor performance and cognition’.
As a result,
“This finding was followed by examination of the moderating effect of age, which identified a Psilocybin only vs psilocybin + HE + B3 * Time *Age interaction (F (1, 732) = 8.4, b = 0.6, p = 0.04), which reflected that the addition of HE and B3 was impactful among older respondents but not among younger respondents.”
now reads:
“This finding was followed by examination of the moderating effect of age, which identified a Psilocybin only vs psilocybin + HE + B3 * Time *Age interaction (F (1, 732) = 8.4, b = 0.6, p = 0.004), which reflected that the addition of HE and B3 was impactful among older respondents but not among younger respondents.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rootman, J.M., Kiraga, M., Kryskow, P. et al. Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Sci Rep 12, 12925 (2022). https://doi.org/10.1038/s41598-022-17428-0
Published:
DOI: https://doi.org/10.1038/s41598-022-17428-0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
